Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
14/10/2026 08:19
BRIEF-Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac Oct 14 (Reuters) - Gen Ilac ve Saglik Urunleri Sanayi Ticaret A.S. GENIL.IS:
GEN ILAC - PARTICIPATES IN KAZAKHSTAN DRUG PROCUREMENT TENDER VIA MED SERVICE PLUS AUTHORİZED BY KAZAKHSTAN REPRESENTATİVE OFFICE OF GEN ILAC
GEN ILAC - ILOPERA PRODUCT WINS FIRST TENDER IN KAZAKHSTAN
GEN ILAC - FIRST DRUG SHİPMENT IS PROJECTED TO TAKE PLACE AT THE END OF NOVEMBER 2026
GEN ILAC - ITS TOTAL CONTRIBUTION TO GEN'S SALES IS EXPECTED TO BE USD 838,620
Source text: ID:nIKA9YFLRC
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira